NIKA
NIKA PHARMACEUTICALS, INCCompany Information
- Company Name
- NIKA PHARMACEUTICALS, INC
- CIK
- CIK0001145604
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- NIKA: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- NIKA
SEC filing data through
Insider Sentiment
- Last purchase
- 2022-04-13
- Last sale
- 2025-03-18
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 2,000,000
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- -19.61%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | - | - | - | - | - | - | - | - | 0 | 0 | - | - | ||||||
| Accounts Receivable Net Current | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Other Receivables Net Current | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Prepaid Expense Current | - | - | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets | 0 | 0 | - | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Property Plant And Equipment | ||||||||||||||||||
| Property Plant And Equipment Net | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Property Plant And Equipment Other Net | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Debt Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | - | - | - | 0 | 0 | - | - | ||||||
| Short Term Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | - | ||||||
| Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | ||||||
| Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 3 | 3 | ||||||
| Retained Earnings Accumulated Deficit | -9 | -9 | -9 | -9 | -9 | -9 | -9 | -9 | -9 | -9 | -3 | -3 | ||||||
| Stockholders Equity | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 10 | ||||||
| Preferred Stock Shares Outstanding | 15 | 15 | 15 | 15 | 15 | 10 | 15 | 15 | 15 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | - | 10 | 10 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 2,700 | 2,700 | 2,700 | 2,700 | 2,700 | 2,700 | 2,700 | 2,700 | 2,700 | 2,700 | 2,700 | 2,700 | ||||||
| Common Stock Shares Issued | 1,052 | 1,049 | 1,048 | 1,040 | 1,026 | 1,026 | 1,048 | 1,019 | 1,019 | 876 | 876 | 876 | ||||||
| Shares Outstanding | 1,052 | 1,049 | 1,048 | 1,040 | 1,026 | 1,026 | 1,048 | 1,019 | 1,019 | 876 | 876 | 876 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNIKA PHARMACEUTICALS, INC (NIKA) — SEC Financial Statements & Analysis
NIKA PHARMACEUTICALS, INC (NIKA) is a pharmaceutical preparations company, incorporated in CO. NIKA PHARMACEUTICALS, INC trades on OTC as: NIKA. NIKA PHARMACEUTICALS, INC (NIKA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, NIKA PHARMACEUTICALS, INC carries a market cap of $808.75M, a P/E ratio of -10351.99x, a P/B ratio of -2445.70x, a P/S ratio of 6579301.28x, an enterprise value of $809.09M, and an EV/EBITDA multiple of -10356.31x. On profitability, it posts an operating margin of -40246.79%, a net margin of -78211.54%, a Return on Equity (ROE) of 26.79%, a Return on Assets (ROA) of -376.06%, and a Return on Invested Capital (ROIC) of -679.32%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 196.31% year-over-year, and EPS growth of 189.19% year-over-year. On the balance sheet, it maintains a current ratio of 0.03x, a quick ratio of 0.03x, working capital of $-330.68K, a debt-to-equity ratio of -1.03x, a debt ratio of 34.26, free cash flow of $-69.14K (TTM), and net debt of $337.69K. Figures sourced from SEC EDGAR.
- Market Cap
- $808.75M
- P/E TTM
- -10351.99x
- EPS TTM
- $-0.00
- P/B TTM
- -2445.70x
- ROE TTM
- 26.79%
- ROA TTM
- -376.06%
- Debt To Equity
- -1.03x
- Free Cash Flow TTM
- $-69.14K
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is NIKA PHARMACEUTICALS, INC in?
NIKA PHARMACEUTICALS, INC (NIKA) operates in the Pharmaceutical Preparations industry.
What exchange does NIKA trade on?
NIKA PHARMACEUTICALS, INC (NIKA) trades on the OTC.
Where is NIKA PHARMACEUTICALS, INC incorporated?
NIKA PHARMACEUTICALS, INC is incorporated in CO.
When was NIKA PHARMACEUTICALS, INC (NIKA)'s most recent SEC filing?
NIKA PHARMACEUTICALS, INC (NIKA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is NIKA's market cap?
NIKA PHARMACEUTICALS, INC (NIKA) has a market capitalization of $808.75M as of 2026-06-30.
What is NIKA's EPS (earnings per share)?
NIKA PHARMACEUTICALS, INC (NIKA)'s trailing twelve month EPS is $-0.00 as of 2026-06-30.
What is NIKA's ROE (return on equity)?
NIKA PHARMACEUTICALS, INC (NIKA)'s trailing twelve month Return on Equity (ROE) is 26.79% as of 2026-06-30.
What is NIKA's ROA (return on assets)?
NIKA PHARMACEUTICALS, INC (NIKA)'s trailing twelve month Return on Assets (ROA) is -376.06% as of 2026-06-30.
What is NIKA's ROIC (return on invested capital)?
NIKA PHARMACEUTICALS, INC (NIKA)'s trailing twelve month Return on Invested Capital (ROIC) is -679.32% as of 2026-06-30.
What is NIKA's EV/EBITDA?
NIKA PHARMACEUTICALS, INC (NIKA)'s trailing twelve month EV/EBITDA is -10356.31x as of 2026-06-30.